Compare IIIN & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IIIN | POM |
|---|---|---|
| Founded | 1953 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Other Specialty Stores |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 639.8M | 555.4M |
| IPO Year | N/A | 2025 |
| Metric | IIIN | POM |
|---|---|---|
| Price | $31.58 | $0.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 135.4K | ★ 6.2M |
| Earning Date | 01-15-2026 | 12-03-2025 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | ★ 112.14 | N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $647,706,000.00 | $51,210,721.00 |
| Revenue This Year | $14.97 | N/A |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | $15.08 | ★ N/A |
| Revenue Growth | ★ 22.39 | 12.13 |
| 52 Week Low | $22.49 | $0.26 |
| 52 Week High | $41.64 | $6.43 |
| Indicator | IIIN | POM |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | N/A |
| Support Level | $31.93 | N/A |
| Resistance Level | $32.64 | N/A |
| Average True Range (ATR) | 0.80 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 18.40 | 0.00 |
Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.